Eko Analysis Software vs Viz AAA

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Eko Health
VS
by Viz.ai

AI Verdict

While both are FDA-cleared AI tools in cardiology, Eko Analysis Software focuses on the early detection of heart murmurs and atrial fibrillation using digital stethoscopes and ECGs. In contrast, Viz AAA specializes in the AI-powered detection and triage of suspected Abdominal Aortic Aneurysms from CT angiography scans. Therefore, they address different cardiovascular pathologies and leverage distinct diagnostic modalities.

Choose Eko Analysis Software if…

Choose Eko Analysis Software if your practice requires an accessible, AI-powered solution for routine cardiovascular screening and early detection of common conditions like heart murmurs and atrial fibrillation at the point of care. This tool is ideal for clinicians seeking to augment their auscultation skills with AI insights, record and track heart sounds and ECGs, and facilitate telehealth consultations for ongoing patient monitoring.

View Eko Analysis Software →

Choose Viz AAA if…

Choose Viz AAA if your hospital or emergency department needs an AI-driven solution to rapidly detect and prioritize suspected Abdominal Aortic Aneurysms from CT angiography scans. This tool is best suited for accelerating critical care pathways by providing real-time alerts and a secure communication platform to multidisciplinary teams, thereby improving time-sensitive treatment decisions for a life-threatening condition.

View Viz AAA →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Eko Analysis Software Viz AAA
Pricing Unknown Enterprise (hospital/health system)
Deployment Unknown Cloud-based, integrates with PACS and EHR systems.
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Eko Analysis Software

Eko Analysis Software integrates with digital stethoscopes and a mobile app, offering an intuitive experience for frontline clinicians at the point of care. Its design for mobile use with a familiar tool like the stethoscope lowers the barrier to adoption. While Viz AAA integrates well into hospital workflows, Eko's direct device interaction provides broader, more immediate usability for individual practitioners.

Clinical Value

Tie

Both tools offer significant and FDA-cleared clinical value in their specialized areas. Eko Analysis Software provides AI-powered early detection of heart murmurs and AFib, with studies demonstrating improved detection rates for various cardiac conditions. Viz AAA is the first FDA-cleared AI for rapid detection and triage of suspected AAA, supported by studies showing high sensitivity and specificity.

Pricing & Value

Eko Analysis Software

Eko Analysis Software offers a transparent freemium model, allowing users to access basic features for free before subscribing for full AI capabilities. This approach provides flexibility and a clear understanding of costs upfront. In contrast, Viz AAA uses a subscription model with non-public pricing tiers, requiring direct engagement for cost information.

Enterprise Readiness

Viz AAA

Viz AAA is explicitly designed for seamless integration into existing hospital workflows, including EHR and PACS systems, and provides real-time alerts to multidisciplinary care teams. Its widespread deployment in over 2,000 hospitals and focus on care coordination demonstrate superior enterprise readiness. While Eko offers enterprise features and integrations, Viz AAA's core design and adoption are more geared towards complex health system environments.

Innovation

Tie

Both tools represent significant innovation in their respective domains. Eko Analysis Software innovates by modernizing the traditional stethoscope with AI for early, non-invasive cardiac disease detection. Viz AAA is a pioneering solution, being the first FDA-cleared AI for AAA detection and triage from CTA scans, accelerating critical care pathways.

Support & Docs

Viz AAA

Viz AAA offers robust customer support, including 24/7/365 urgent phone support, email support, a comprehensive help center, and a knowledge base. This round-the-clock availability is crucial for a tool involved in time-sensitive, high-acuity clinical decisions. Eko provides email and scheduled phone support, along with a help center, but lacks the immediate, 24/7 phone support offered by Viz.ai.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Eko Analysis Software Viz AAA
Product Name Eko Analysis Software Viz AAA
Company Eko Devices Viz.ai
Core Function AI-powered tool for early detection of cardiovascular diseases like heart murmurs and atrial fibrillation, integrating with digital stethoscopes and a mobile app. AI-powered solution for detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans, designed to accelerate diagnosis and care coordination.
Primary AI Detection Focus Heart murmurs, atrial fibrillation (AFib), normal sinus rhythm Suspected Abdominal Aortic Aneurysm (AAA) from CTA scans
Applicable Specialties Cardiology, Emergency Medicine, Internal Medicine Emergency Medicine, Radiology, Vascular Surgery
Key Workflow Integration Integrates with Eko's digital stethoscopes and mobile app for wireless auscultation, recording, and visualization of heart sounds and ECGs. Integrates into existing hospital workflows, provides real-time alerts to care teams, and includes a HIPAA-compliant communication platform.

Videos

Demos, reviews, and walkthroughs featuring Eko Analysis Software and Viz AAA.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Eko Analysis Software is an FDA-cleared AI-powered tool designed for the early detection of cardiovascular diseases such as heart murmurs and atrial fibrillation, and also detects normal sinus rhythm. In contrast, Viz AAA is the first FDA-cleared AI-powered solution for the detection and triage of suspected Abdominal Aortic Aneurysm (AAA).
Eko Analysis Software integrates with Eko's digital stethoscopes and mobile app to analyze heart sounds (phonocardiograms) and ECGs. Viz AAA analyzes data directly from CT angiography scans to detect suspected AAA.
Eko Analysis Software is primarily used in Cardiology, Emergency Medicine, and Internal Medicine. Viz AAA is tailored for Emergency Medicine, Radiology, and Vascular Surgery specialties.
Eko Analysis Software offers FDA-cleared AI for heart murmur and AFib detection, along with recording, playback, and visualization of heart sounds and ECGs. Viz AAA provides AI-powered automatic detection and automated triage of suspected AAA from CTA scans, integrating into existing hospital workflows with real-time alerts and a HIPAA-compliant communication platform for care teams.

Backers

Who funded each tool's parent company.

Eko Analysis Software

AI Tool Finder
AI-powered search. Results may not be comprehensive.